Study finds sildenafil as candidate drug for Alzheimer’s disease
January 4, 2022
A new study by the Cleveland Clinic has found that sildenafil, an FDA-approved therapy for erectile dysfunction and pulmonary hypertension, is a promising drug candidate to help prevent and treat Alzheimer’s disease. The research team, led by Feixiong Cheng, Ph.D., of Cleveland Clinic’s Genomic Medicine Institute, used computational methodology to...
Read More